NeoGenomics Laboratories, Inc. (NEO): Rep. Dwight Evans (PA03) disclosed a sale $1K–$15K
Rep. Dwight Evans (PA03) disclosed a sale of NeoGenomics Laboratories, Inc. in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 26 days
- Disclosure lag
- Traded
- Mar 30, 2022
- Disclosed
- Apr 25, 2022
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for NeoGenomics Laboratories, Inc.
For NeoGenomics Laboratories, Inc., OQRO holds 1 Congress trade report dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NEO page.
Other recent filings by Rep. Dwight Evans (PA03)
- House Clerk periodic transaction report at General Dynamics (GD)Jun 24, 2026
- House Clerk periodic transaction report at Intel (INTC)Jun 24, 2026
- House Clerk periodic transaction report at American Tower (AMT)May 15, 2026
- House Clerk periodic transaction report at CVS Health (CVS)May 15, 2026
- House Clerk periodic transaction report at Intel (INTC)May 15, 2026
The full history of Rep. Dwight Evans (PA03) is on the profile page.
How this filing works
Explore the data
Other disclosures at NeoGenomics Laboratories, Inc.
- House Clerk periodic transaction reportSep 10, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- USAspending.gov award recordJun 17, 2026
- USAspending.gov award recordJun 11, 2026
- SEC Form 13F-HRMay 22, 2026
Everything OQRO holds on this company is on its NEO page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
